Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
Condition(s):Immune ThrombocytopeniaLast Updated:December 8, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Immune ThrombocytopeniaLast Updated:December 8, 2023Recruiting
Condition(s):Primary Immune ThrombocytopeniaLast Updated:March 26, 2024Recruiting
Condition(s):ITP – Immune ThrombocytopeniaLast Updated:November 18, 2023Not yet recruiting
Condition(s):ITP; Immune ThrombocytopeniaLast Updated:September 28, 2022Recruiting
Condition(s):COVID-19 VaccineLast Updated:July 13, 2022Recruiting
Condition(s):Primary Immune ThrombocytopeniaLast Updated:March 18, 2024Recruiting
Condition(s):ITP; Immune ThrombocytopeniaLast Updated:May 2, 2022Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:July 15, 2022Not yet recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:August 30, 2022Recruiting
Condition(s):Primary Immune Thrombocytopenia (ITP)Last Updated:September 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.